ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.22
-0.93%
US Tech 100
18,490.00
-0.24%
S&P 500
5,346.99
-0.11%
US Dollar vs CAD
1.37765
0.79%
Bitcoin
69,294.93
-0.05%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Genenta Science SPA (GNTA)

  7. Genenta Science SPA (GNTA) News

GNTA

Genenta Science (GNTA)

Genenta Science SPA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GNTA
DateTimeSourceHeadlineSymbolCompany
05/06/20245:25AMGlobeNewswire Inc.Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd WiderNASDAQ:GNTAGenenta Science SPA
02/12/20243:05PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GNTAGenenta Science SPA
02/08/20244:00AMGlobeNewswire Inc.Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid TumorsNASDAQ:GNTAGenenta Science SPA
10/20/20233:15PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GNTAGenenta Science SPA
09/06/20236:00AMGlobeNewswire Inc.Genenta to Present at Upcoming Scientific and Investor ConferencesNASDAQ:GNTAGenenta Science SPA
07/28/20232:00AMGlobeNewswire Inc.Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor TreatmentsNASDAQ:GNTAGenenta Science SPA
06/29/20236:00AMGlobeNewswire Inc.The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of GliomaNASDAQ:GNTAGenenta Science SPA
05/25/20235:04AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNTAGenenta Science SPA
05/16/20236:00AMGlobeNewswire Inc.Genenta to Provide Update on Lead Product Temferon™NASDAQ:GNTAGenenta Science SPA
05/12/20234:13PMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:GNTAGenenta Science SPA
05/01/20233:06PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNTAGenenta Science SPA
04/26/20236:00AMGlobeNewswire Inc.Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F FilingNASDAQ:GNTAGenenta Science SPA
04/21/20234:23PMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:GNTAGenenta Science SPA
03/10/20233:49PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNTAGenenta Science SPA
02/10/20235:10AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNTAGenenta Science SPA
02/01/20234:29PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNTAGenenta Science SPA
12/22/20223:12PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNTAGenenta Science SPA
10/26/20225:45PMTipRanksMaxim Group Remains a Buy on Genenta Science SpA Sponsored ADR (GNTA)NASDAQ:GNTAGenenta Science SPA
10/25/20224:14PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNTAGenenta Science SPA
10/03/20226:17AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNTAGenenta Science SPA
07/25/20225:00AMGlobeNewswire Inc.AmCham Italy and Genenta Science Announce the Bowling Green Bull InitiativeNASDAQ:GNTAGenenta Science SPA
06/14/20224:12PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:GNTAGenenta Science SPA
06/15/20099:47AMPR Newswire (US)The following is an investment opinion release issued by EmergingStockReport.comNASDAQ:GNTA
05/15/20099:48AMPR Newswire (US)Stock Alerts on Market Movers: NGRN, RMBS, NVLS, LVS, GNTA, AN; Issued by Beacon EquityNASDAQ:GNTA
03/06/20096:36PMDow Jones NewsGenta: FDA Favors Clinical Trial For Leukemia Drug GenasenseNASDAQ:GNTAGenta Inc.
03/06/20095:34PMBusiness WireFDA Appeal Decision Indicates that Genasense® Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory ...NASDAQ:GNTAGenenta Science SPA
02/13/20093:10PMBusiness WireGenta Incorporated Announces Fourth Quarter and Year End 2008 Financial Results and Corporate HighlightsNASDAQ:GNTAGenenta Science SPA
01/07/200912:02PMPR Newswire (US)Beacon Equity Issues Technical Trade Alerts on Newsworthy Market Movers: WLT, SSCC, FNSR, CHTR, STSI, GNTANASDAQ:GNTA
09/15/20087:05AMPR Newswire (US)Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced MelanomaNASDAQ:GNTA
08/07/20087:00AMPR Newswire (US)Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate HighlightsNASDAQ:GNTA
 Showing the most relevant articles for your search:NASDAQ:GNTA

Your Recent History

ASX
SMZ
Stirling Minerals
EU
BNEW
Euronext BeNe 40 Equal W...
NYSE
CLVT-A
Clarivate
NYSE
GNPK
Genesis Park Acquisition
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved